NCT00220727 - Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Purpura, Thrombocytopenic, Idiopathic

Interventions

DRUG

Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified

IGIV-C 10% at a dose of 1.0g/kg was to be given on 2 occasions as a single daily infusion: Group 1 were to receive their first IGIV-C, 10-% infusion at a rate of 0.08 mL/kg/min and a second infusion at 0.14 mL/kg/min. and Group 2 were to receive their first IGIV-C, 10-% infusion at a rate of 0.14 mL/kg/min and a second infusion at a rate of 0.08 mL/kg/min.

Trial Locations (1)

10021-4885

New York Presbyterian Hospital, New York